From 2012 to 2015, the market for Penicillins and Streptomycins in South Africa exhibited a stable growth, with year-on-year increases around 4%. A peak was reached in 2015 with a value of 171.08 million USD. However, subsequent years showed volatility with significant declines: a 3.98% drop in 2016, followed by more steep declines in 2017 (-4.15%) and 2018 (-9.6%). Despite minor recoveries in 2020 and 2021, the overall trend from 2016 to 2022 indicates a negative trajectory, with a decline culminating in a market value of 142.82 million USD in 2022.
Looking ahead to 2024 and beyond, key future trends to watch for include:
- Pharmaceutical advancements and innovations in antibiotic treatments.
- Changing healthcare regulations and their impact on drug pricing.
- Market competition and the entry of generic medications.
- Public health initiatives promoting antibiotic stewardship and their effect on demand.
- Potential economic volatility affecting healthcare budget allocations.
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 10 | 10 Spain | 197,590,000 | 2023 | -1.96% | -2.19% | View data |
| 11 | 11 Poland | 143,340,000 | 2023 | -0.61% | -1.38% | View data |
| 12 | 12 South Africa | 142,320,000 | 2023 | -0.66% | -0.0042% | |
| 13 | 13 Belgium | 129,530,000 | 2023 | +1.01% | +0.63% | View data |
| 14 | 14 Thailand | 89,928,000 | 2023 | +4.19% | +3.03% | View data |
